BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: da Ponte Neto AM, Clemente ACO, Rosa PW, Ribeiro IB, Funari MP, Nunes GC, Moreira L, Sparvoli LG, Cortez R, Taddei CR, Mancini MC, de Moura EGH. Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial. World J Clin Cases 2023; 11(19): 4612-4624 [PMID: 37469721 DOI: 10.12998/wjcc.v11.i19.4612]
URL: https://www.wjgnet.com/2307-8960/full/v11/i19/4612.htm
Number Citing Articles
1
Panagiotis Theofilis, Panayotis K. Vlachakis, Evangelos Oikonomou, Konstantinos Tsioufis, Dimitris Tousoulis. Targeting the Gut Microbiome to Treat Cardiometabolic DiseaseCurrent Atherosclerosis Reports 2024; 26(2): 25 doi: 10.1007/s11883-023-01183-2
2
Gulshara Zh Abildinova, Valeriy V. Benberin, Tamara A. Vochshenkova, Alireza Afshar, Nadiar M. Mussin, Asset A. Kaliyev, Zhanna Zhussupova, Amin Tamadon. Global trends and collaborative networks in gut microbiota-insulin resistance research: a comprehensive bibliometric analysis (2000–2024)Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1452227
3
Daniel P. Baars, Marcos F. Fondevila, Abraham S. Meijnikman, Max Nieuwdorp. The central role of the gut microbiota in the pathophysiology and management of type 2 diabetesCell Host & Microbe 2024; 32(8): 1280 doi: 10.1016/j.chom.2024.07.017